Therapeutic efficacy and safety of a human fusion construct targeting the TWEAK receptor Fn14 and containing a modified granzyme B
Ana Álvarez‐Cienfuegos(The University of Texas MD Anderson Cancer Center), Michael G. Rosenblum(The University of Texas MD Anderson Cancer Center)
Cited by 14
Related Papers
Liposomal Amphotericin B for the Treatment of Systemic Fungal Infections in Patients with Cancer: A Preliminary Study
|The Journal of Infectious Diseases|1985|408
The immunocytokine scFv23/TNF sensitizes HER-2/neu–overexpressing SKBR-3 cells to tumor necrosis factor (TNF) via up-regulation of TNF receptor-1
|Molecular Cancer Therapeutics|2005|25